Skip to content

Straumann® BLC and TLC Implants SLA Roxolid BL (REF 035.9510S)Recalls & reported problems

Institut Straumann AG · BLC Implant, Ø 5.0mm WB, SLActive 10mm, Roxolid · Class 2 · Implant

All models of Straumann BLC and TLC Implants (153)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann BLC implant is an endosseous root-form dental implant. The 98 reports mostly describe the implant failing to osseointegrate, sometimes with pain, mobility, swelling, or inflammation. There are 98 reports, no deaths, and 98 injuries; no recalls name this device. All 98 reports came in the last 12 months, versus 0 in the prior 12 months.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
113
Deaths reported
0
Injuries reported
113
Recalls naming it
0

Summary

The FDA's MAUDE database contains 113 adverse event reports that list this exact device (DI 07630031780157), received between Jan 30, 2026 and Sep 28, 2026 — classified as 113 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (78 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 2 reportsFeb 2026: 2 reportsMar 2026: 8 reportsApr 2026: 13 reportsMay 2026: 11 reportsJun 2026: 17 reportsJul 2026: 16 reportsAug 2026: 24 reportsSep 2026: 20 reportsOct 2026: 0 reports20242025202624
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate78
  • Adverse Event Without Identified Device or Use Problem19
  • Difficult to Insert8
  • Loss of Osseointegration6
  • Separation Failure2

Patient problems

  • No Clinical Signs, Symptoms or Conditions57
  • Fibrosis44
  • Pain14
  • Hyperresponsive to stimuli13
  • Unspecified Infection10
  • Inflammation9
  • Abscess4
  • Swelling/ Edema3

Recent adverse event reports

The 25 most recent of 113 reports, in the reporter's own words as published by the FDA.

  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50920456 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Abscess; Inflammation; Pain; Unspecified Infection

    MAUDE report 50920115 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50918683 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Abscess; Inflammation; Pain; Unspecified Infection

    MAUDE report 50918554 ↗
  • InjurySep 14, 2026Adverse Event Without Identified Device or Use Problem

    Patient problems: Fibrosis

    MAUDE report 50760871 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli; Inflammation; Pain

    MAUDE report 50760850 ↗
  • InjurySep 14, 2026Difficult to Insert

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50760712 ↗
  • InjurySep 14, 2026Difficult to Insert

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50760561 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759772 ↗
  • InjurySep 14, 2026Difficult to Insert

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759717 ↗
  • InjurySep 14, 2026Adverse Event Without Identified Device or Use Problem

    Patient problems: Fibrosis

    MAUDE report 50757972 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in ADA 14. Details of surgery: Implant surface not completely covered with bone. On (B)(6) 2026, non-osseointegration was verified. Patient presented with previous bone augmentation. The device was forwarded to the manufacturer. At the event the patient experienced: Pain, Increased Sensitivity and Inflammation. No further patient complications were reported.

    Patient problems: Hyperresponsive to stimuli; Inflammation; Pain

    MAUDE report 50757952 ↗
  • InjurySep 14, 2026Difficult to Insert

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50757913 ↗
  • InjurySep 14, 2026Difficult to Insert

    The clinician reports that the day the implant was placed in ADA 19, failure occurred upon insertion. Patient presented with bone type III. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50757892 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50757761 ↗
  • InjurySep 14, 2026Difficult to Insert

    The clinician reports that the day the implant was placed in ADA 19, failure occurred upon insertion. Details of surgery: Primary stability not achieved. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50757701 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50719688 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50719662 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted 2026 (b)(6) in ADA 30. On 2026 (b)(6), non-osseointegration was verified. No product was returned to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50718805 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted 2026 (b)(6) in ADA 3. Details of surgery: Primary stability not achieved. On 2026 (b)(6), non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50718778 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Hyperresponsive to stimuli; Inflammation; Pain; Swelling/ Edema

    MAUDE report 50416212 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50415053 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Hyperresponsive to stimuli; Inflammation; Pain; Swelling/ Edema

    MAUDE report 50413565 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in ADA 15. On (B)(6) 2026, non-osseointegration was verified. Patient presented with bone type III and previous bone augmentation. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50413224 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 27. On (b)(6) 2026, non-osseointegration was verified. Patient presented with bone type III. The device was forwarded to the manufacturer. At the event the patient experienced: Pain, Mobility, Swelling and Inflammation. No further patient complications were reported.

    Patient problems: Fibrosis; Inflammation; Pain; Swelling/ Edema

    MAUDE report 50284321 ↗

Other Implant, endosseous, root-form devices

All Implant, endosseous, root-form devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page